Statistics at a Glance
At a Glance
Estimated New Cases in 2020 81,400
% of All New Cancer Cases 4.5%
Estimated Deaths in 2020 17,980
% of All Cancer Deaths 3.0%
|Year||Rate of New Cases — SEER 9||Rate of New Cases — SEER 13||Death Rate — U.S.||5-Year Relative Survival — SEER 9|
|Observed||Modeled Trend||Observed||Modeled Trend||Observed||Modeled Trend||Observed||Modeled Trend|
New cases come from SEER 13. Deaths come from U.S. Mortality.
All Races, Both Sexes. Rates are Age-Adjusted.
Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software.
New cases are also referred to as incident cases in other publications. Rates of new cases are also referred to as incidence rates.
Rate of New Cases and Deaths per 100,000: The rate of new cases of bladder cancer was 20.0 per 100,000 men and women per year. The death rate was 4.4 per 100,000 men and women per year. These rates are age-adjusted and based on 2013–2017 cases and deaths.
Lifetime Risk of Developing Cancer: Approximately 2.4 percent of men and women will be diagnosed with bladder cancer at some point during their lifetime, based on 2015–2017 data.
Prevalence of This Cancer: In 2017, there were an estimated 712,614 people living with bladder cancer in the United States.
How Many People Survive 5 Years Or More after Being Diagnosed with Bladder Cancer?
Relative survival is an estimate of the percentage of patients who would be expected to survive the effects of their cancer. It excludes the risk of dying from other causes. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.
Based on data from SEER 18 2010–2016. Gray figures represent those who have died from bladder cancer. Green figures represent those who have survived 5 years or more.
Survival by Stage
Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. The earlier bladder cancer is caught, the better chance a person has of surviving five years after being diagnosed. For bladder cancer, 33.7% are diagnosed at the local stage. The 5-year relative survival for localized bladder cancer is 69.2%.
|Stage||Percent of Cases||5-Year Relative Survival|
Only in Originating Layer of Cells
Confined to Primary Site
Spread to Regional Lymph Nodes
Cancer Has Metastasized
SEER 18 2010–2016, All Races, Both Sexes by SEER Summary Stage 2000
New Cases and Deaths
How Common Is This Cancer?
Compared to other cancers, bladder cancer is fairly common.
|Rank||Common Types of Cancer||Estimated New
|1.||Breast Cancer (Female)||276,480||42,170|
|2.||Lung and Bronchus Cancer||228,820||135,720|
|5.||Melanoma of the Skin||100,350||6,850|
|8.||Kidney and Renal Pelvis Cancer||73,750||14,830|
Bladder cancer represents 4.5% of all new cancer cases in the U.S.
In 2020, it is estimated that there will be 81,400 new cases of bladder cancer and an estimated 17,980 people will die of this disease.
Who Gets This Cancer?
Bladder cancer becomes more common with age and is more common in men than women. The rate of new cases of bladder cancer was 20.0 per 100,000 men and women per year based on 2013–2017 cases, age-adjusted.
|American Indian/Alaska Native||16.3|
|American Indian/Alaska Native||4.5|
SEER 21 2013–2017, Age-Adjusted
|Age Range||Percent of New Cases|
Bladder cancer is most frequently diagnosed among people aged 65–74.
SEER 21 2013–2017, All Races, Both Sexes
Who Dies From This Cancer?
Bladder cancer is the tenth leading cause of cancer death in the United States. The death rate was 4.4 per 100,000 men and women per year based on 2013–2017 deaths, age-adjusted.
|American Indian/Alaska Native||4.2|
|American Indian/Alaska Native||1.7|
U.S. 2013–2017, Age-Adjusted
|Age Range||Percent of Deaths|
The percent of bladder cancer deaths is highest among people aged 75–84.
U.S. 2013–2017, All Races, Both Sexes
Trends in Rates
Changes Over Time
Keeping track of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.
Using statistical models for analysis, age-adjusted rates for new bladder cancer cases have been falling on average 1.2% each year over the last 10 years. Age-adjusted death rates have been stable over 2008–2017. 5-year relative survival trends are shown below.
Interactive Statistics with SEER*Explorer
- Create custom graphs and tables
- Download data and images
- Share links to results
SEER*Explorer is an interactive website that provides easy access to a wide range of SEER cancer statistics. It provides detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.Explore Additional Bladder Cancer Statistics
More About This Cancer
Cancer and the Bladder
and female urinary system (right)
Figure: Anatomy of the male urinary system (left) and female urinary system (right) showing the kidneys, ureters, bladder, and urethra.
The bladder is a hollow organ in the lower part of the abdomen. It is shaped like a small balloon and has a muscular wall that allows it to get larger or smaller. The urine passes from the two kidneys into the bladder through two tubes called ureters. The bladder is emptied through another tube called the urethra.
Cancer that is confined to the lining of the bladder is called superficial bladder cancer. Cancer that begins in the transitional cells may spread through the lining of the bladder and invade the muscle wall of the bladder or spread to nearby organs and lymph nodes; this is called invasive bladder cancer.
Here are some resources for learning more about bladder cancer.
- About risk factors for bladder cancer
- About symptoms and diagnosis of bladder cancer
- About treatment options for bladder cancer
- About clinical trials
- About cancer prevention
- About the health risks of smoking and ways to quit
All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within:
Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2017, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2017/, based on November 2019 SEER data submission, posted to the SEER web site, April 2020.
All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
SEER Cancer Stat Facts: Bladder Cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/urinb.html
These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse the SEER Cancer Statistics Review. To see statistics for a specific state, go to the State Cancer Profiles.
The statistics presented in these stat facts are based on the most recent data available, most of which can be found in the SEER Cancer Statistics Review. In some cases, different year spans may be used.
Estimates of new cases and deaths for 2020 are projections made by the American Cancer Society (ACS), based on earlier reported data.
Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.